$60.38
0.240.40%
At Close: -
$60.38
00.00%
After Hours: 4:38 PM EDT
15 minutes delayed
Nasdaq
NDAQNASDAQ
want to know what
the Bulls & Bears Say?
Nasdaq (NASDAQ:NDAQ) Stock, Analyst Ratings, Price Targets, Forecasts
Nasdaq Inc has a consensus price target of $99.75 based on the ratings of 95 analysis. The 3 most-recent analyst ratings were released by Argus Research, Rosenblatt, and Barclays on May 14, 2024, May 8, 2024, and April 26, 2024, respectively. With an average price target of $67.67 between Argus Research, Rosenblatt, and Barclays, there's an implied 12.07% upside for Nasdaq Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Argus Research
Rosenblatt
Barclays
Keefe, Bruyette & Woods
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Nasdaq
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | Buy Now | 9.31% | Argus Research | Kevin Heal | $64 → $66 | Maintains | Buy | Get Alert |
| 05/08/2024 | Buy Now | 6% | Rosenblatt | Andrew Bond | $76 → $64 | Downgrade | Buy → Neutral | Get Alert |
| 04/26/2024 | Buy Now | 20.9% | Barclays | Benjamin Budish | $76 → $73 | Maintains | Overweight | Get Alert |
| 04/26/2024 | Buy Now | 22.56% | Keefe, Bruyette & Woods | Kyle Voigt | $75 → $74 | Maintains | Outperform | Get Alert |
| 04/26/2024 | Buy Now | 25.87% | Rosenblatt | Andrew Bond | $82 → $76 | Maintains | Buy | Get Alert |
| 04/11/2024 | Buy Now | 25.87% | Barclays | Benjamin Budish | → $76 | Initiates | → Overweight | Get Alert |
| 04/09/2024 | Buy Now | 32.49% | Morgan Stanley | Michael Cyprys | $59 → $80 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/26/2024 | Buy Now | 20.9% | Goldman Sachs | Alexander Blostein | → $73 | Upgrade | Neutral → Buy | Get Alert |
| 02/01/2024 | Buy Now | 17.59% | Piper Sandler | Richard Repetto | $70 → $71 | Maintains | Overweight | Get Alert |
| 02/01/2024 | Buy Now | 12.62% | Oppenheimer | Owen Lau | $65 → $68 | Maintains | Outperform | Get Alert |
| 02/01/2024 | Buy Now | 35.81% | Rosenblatt | Andrew Bond | → $82 | Reiterates | Buy → Buy | Get Alert |
| 01/24/2024 | Buy Now | -0.63% | UBS | Alex Kramm | $56 → $60 | Maintains | Neutral | Get Alert |
| 01/12/2024 | Buy Now | 4.34% | Citigroup | Christopher Allen | $56 → $63 | Maintains | Neutral | Get Alert |
| 12/01/2023 | Buy Now | -3.94% | Goldman Sachs | Alexander Blostein | → $58 | Reinstates | → Neutral | Get Alert |
| 10/19/2023 | Buy Now | 4.34% | JP Morgan | Michael Cho | $62 → $63 | Maintains | Overweight | Get Alert |
| 10/19/2023 | Buy Now | -8.91% | Morgan Stanley | Michael Cyprys | $54 → $55 | Maintains | Equal-Weight | Get Alert |
| 10/19/2023 | Buy Now | 7.65% | Oppenheimer | Owen Lau | → $65 | Reiterates | Outperform → Outperform | Get Alert |
| 10/19/2023 | Buy Now | 35.81% | Rosenblatt | Andrew Bond | → $82 | Reiterates | Buy → Buy | Get Alert |
| 10/12/2023 | Buy Now | 35.81% | Rosenblatt | Andrew Bond | → $82 | Reiterates | Buy → Buy | Get Alert |
| 10/11/2023 | Buy Now | -10.57% | Morgan Stanley | Michael Cyprys | $55 → $54 | Maintains | Equal-Weight | Get Alert |
| 07/25/2023 | Buy Now | -8.91% | Morgan Stanley | Michael Cyprys | $55 → $55 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/20/2023 | Buy Now | 35.81% | Rosenblatt | Andrew Bond | → $82 | Reiterates | Buy → Buy | Get Alert |
| 07/13/2023 | Buy Now | -8.91% | Morgan Stanley | Michael Cyprys | $60 → $55 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | Buy Now | 35.81% | Rosenblatt | Andrew Bond | → $82 | Reiterates | Buy → Buy | Get Alert |
| 06/13/2023 | Buy Now | -12.22% | Deutsche Bank | Brian Bedell | $56 → $53 | Maintains | Hold | Get Alert |
| 06/13/2023 | Buy Now | -7.25% | UBS | Alex Kramm | $62 → $56 | Maintains | Neutral | Get Alert |
| 06/13/2023 | Buy Now | 35.81% | Rosenblatt | Andrew Bond | → $82 | Reiterates | Buy → Buy | Get Alert |
| 04/20/2023 | Buy Now | 35.81% | Rosenblatt | Andrew Bond | → $82 | Reiterates | → Buy | Get Alert |
| 04/20/2023 | Buy Now | 7.65% | Oppenheimer | Owen Lau | $64 → $65 | Maintains | Outperform | Get Alert |
| 04/12/2023 | Buy Now | 6% | Oppenheimer | Owen Lau | $66 → $64 | Maintains | Outperform | Get Alert |
| 04/11/2023 | Buy Now | 35.81% | Rosenblatt | Andrew Bond | → $82 | Reiterates | → Buy | Get Alert |
| 04/11/2023 | Buy Now | -0.63% | Morgan Stanley | Michael Cyprys | $70 → $60 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/30/2023 | Buy Now | -5.6% | Credit Suisse | Gautam Sawant | $59 → $57 | Maintains | Neutral | Get Alert |
| 01/26/2023 | Buy Now | 10.96% | Keefe, Bruyette & Woods | Kyle Voigt | $73 → $67 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | 15.93% | Piper Sandler | Richard Repetto | $73.33 → $70 | Maintains | Overweight | Get Alert |
| 01/26/2023 | Buy Now | 9.31% | Oppenheimer | Owen Lau | $71 → $66 | Maintains | Outperform | Get Alert |
| 01/26/2023 | Buy Now | 10.96% | JP Morgan | Michael Cho | $70 → $67 | Maintains | Overweight | Get Alert |
| 01/26/2023 | Buy Now | 35.81% | Rosenblatt | Andrew Bond | $84 → $82 | Maintains | Buy | Get Alert |
| 01/26/2023 | Buy Now | -0.63% | Deutsche Bank | Brian Bedell | $72 → $60 | Downgrade | Buy → Hold | Get Alert |
| 01/20/2023 | Buy Now | 20.9% | Morgan Stanley | Michael Cyprys | $72 → $73 | Maintains | Overweight | Get Alert |
| 01/17/2023 | Buy Now | -2.29% | Credit Suisse | Gautam Sawant | $58 → $59 | Maintains | Neutral | Get Alert |
| 01/12/2023 | Buy Now | 20.9% | Keefe, Bruyette & Woods | Kyle Voigt | $72 → $73 | Maintains | Outperform | Get Alert |
| 01/11/2023 | Buy Now | 19.24% | Morgan Stanley | Michael Cyprys | $73 → $72 | Maintains | Overweight | Get Alert |
| 11/15/2022 | Buy Now | 17.59% | Deutsche Bank | Brian Bedell | $70 → $71 | Maintains | Buy | Get Alert |
| 11/14/2022 | Buy Now | — | Redburn Partners | Michael Cyprys | — | Initiates | → Neutral | Get Alert |
| 11/09/2022 | Buy Now | 20.9% | Morgan Stanley | Michael Cyprys | $72 → $73 | Maintains | Overweight | Get Alert |
| 11/09/2022 | Buy Now | -3.94% | Credit Suisse | Gautam Sawant | $57 → $58 | Maintains | Neutral | Get Alert |
| 11/02/2022 | Buy Now | -5.6% | Credit Suisse | Gautam Sawant | $66 → $57 | Downgrade | Outperform → Neutral | Get Alert |
| 10/20/2022 | Buy Now | 19.24% | Morgan Stanley | Michael Cyprys | $71 → $72 | Maintains | Overweight | Get Alert |
| 10/20/2022 | Buy Now | 9.31% | Credit Suisse | Gautam Sawant | $64 → $66 | Maintains | Outperform | Get Alert |
| 10/20/2022 | Buy Now | 39.12% | Rosenblatt | Andrew Bond | $80 → $84 | Maintains | Buy | Get Alert |
| 10/14/2022 | Buy Now | -3.94% | B of A Securities | Craig Siegenthaler | $65 → $58 | Downgrade | Buy → Underperform | Get Alert |
| 10/12/2022 | Buy Now | 17.59% | Morgan Stanley | Michael Cyprys | $68 → $71 | Maintains | Overweight | Get Alert |
| 10/12/2022 | Buy Now | 10.96% | Deutsche Bank | Brian Bedell | $68 → $67 | Maintains | Buy | Get Alert |
| 10/12/2022 | Buy Now | 2.68% | Citigroup | Christopher Allen | → $62 | Initiates | → Neutral | Get Alert |
| 10/11/2022 | Buy Now | 6% | Credit Suisse | Gautam Sawant | $66 → $64 | Maintains | Outperform | Get Alert |
| 09/08/2022 | Buy Now | 9.31% | Credit Suisse | Gautam Sawant | $67.33 → $66 | Maintains | Outperform | Get Alert |
| 08/30/2022 | Buy Now | 12.62% | Morgan Stanley | Michael Cyprys | $67 → $68 | Maintains | Overweight | Get Alert |
| 08/29/2022 | Buy Now | 10.96% | Morgan Stanley | Michael Cyprys | $201 → $67 | Maintains | Overweight | Get Alert |
| 08/19/2022 | Buy Now | 231.24% | Atlantic Equities | Simon Clinch | → $66.67 | Downgrade | Overweight → Neutral | Get Alert |
| 08/17/2022 | Buy Now | 299.14% | Rosenblatt | Andrew Bond | → $80.33 | Initiates | → Buy | Get Alert |
| 08/12/2022 | Buy Now | 239.52% | Deutsche Bank | Brian Bedell | $62.67 → $68.33 | Maintains | Buy | Get Alert |
| 07/21/2022 | Buy Now | 232.89% | Morgan Stanley | Michael Cyprys | $65.67 → $67 | Maintains | Overweight | Get Alert |
| 07/21/2022 | Buy Now | 234.55% | Credit Suisse | Gautam Sawant | $63 → $67.33 | Maintains | Outperform | Get Alert |
| 07/19/2022 | Buy Now | 226.27% | Morgan Stanley | Michael Cyprys | $79.67 → $65.67 | Maintains | Overweight | Get Alert |
| 07/14/2022 | Buy Now | 213.02% | Credit Suisse | Gautam Sawant | $73.67 → $63 | Maintains | Outperform | Get Alert |
| 05/19/2022 | Buy Now | 204.74% | Deutsche Bank | Brian Bedell | $69 → $61.33 | Maintains | Buy | Get Alert |
| 04/21/2022 | Buy Now | 242.83% | Deutsche Bank | Brian Bedell | $70 → $69 | Maintains | Buy | Get Alert |
| 04/21/2022 | Buy Now | 295.83% | Morgan Stanley | Michael Cyprys | $81.67 → $79.67 | Maintains | Overweight | Get Alert |
| 04/21/2022 | Buy Now | 237.86% | Rosenblatt | Sean Horgan | $66.33 → $68 | Maintains | Neutral | Get Alert |
| 04/14/2022 | Buy Now | 229.58% | Rosenblatt | Sean Horgan | $66.67 → $66.33 | Maintains | Neutral | Get Alert |
| 04/13/2022 | Buy Now | 305.76% | Morgan Stanley | Michael Cyprys | $79.33 → $81.67 | Maintains | Overweight | Get Alert |
| 03/08/2022 | Buy Now | 231.24% | Rosenblatt | Sean Horgan | $72.67 → $66.67 | Maintains | Neutral | Get Alert |
| 02/18/2022 | Buy Now | 247.8% | Deutsche Bank | Brian Bedell | $75 → $70 | Maintains | Buy | Get Alert |
| 02/15/2022 | Buy Now | 272.64% | Credit Suisse | Gautam Sawant | → $75 | Initiates | → Outperform | Get Alert |
| 02/07/2022 | Buy Now | 231.24% | Argus Research | Kevin Heal | → $66.67 | Upgrade | Hold → Buy | Get Alert |
| 01/27/2022 | Buy Now | 211.36% | Citigroup | Ben Herbert | $66.67 → $62.67 | Maintains | Neutral | Get Alert |
| 01/27/2022 | Buy Now | 272.64% | Deutsche Bank | Brian Bedell | $79 → $75 | Maintains | Buy | Get Alert |
| 01/27/2022 | Buy Now | 259.39% | Oppenheimer | Owen Lau | $76.67 → $72.33 | Maintains | Outperform | Get Alert |
| 01/27/2022 | Buy Now | 272.64% | UBS | Alex Kramm | $79.33 → $75 | Maintains | Buy | Get Alert |
| 01/27/2022 | Buy Now | 294.17% | Morgan Stanley | Michael Cyprys | $84 → $79.33 | Maintains | Overweight | Get Alert |
| 01/27/2022 | Buy Now | 261.05% | Rosenblatt | Sean Horgan | $72 → $72.67 | Maintains | Neutral | Get Alert |
| 01/20/2022 | Buy Now | 257.73% | Rosenblatt | Sean Horgan | $74.67 → $72 | Maintains | Neutral | Get Alert |
| 01/14/2022 | Buy Now | 317.36% | Morgan Stanley | Michael Cyprys | $83.33 → $84 | Maintains | Overweight | Get Alert |
| 01/04/2022 | Buy Now | — | Goldman Sachs | Alexander Blostein | — | Downgrade | Neutral → Sell | Get Alert |
| 12/10/2021 | Buy Now | 270.98% | Rosenblatt | Sean Horgan | — | Maintains | Neutral | Get Alert |
| 10/21/2021 | Buy Now | 264.36% | Rosenblatt | Sean Horgan | — | Maintains | Neutral | Get Alert |
| 10/21/2021 | Buy Now | 314.04% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 10/19/2021 | Buy Now | 317.36% | Morgan Stanley | Michael Cyprys | — | Maintains | Overweight | Get Alert |
| 10/13/2021 | Buy Now | 280.92% | Oppenheimer | — | — | Maintains | Outperform | Get Alert |
| 10/08/2021 | Buy Now | 299.14% | Morgan Stanley | Michael Cyprys | — | Maintains | Overweight | Get Alert |
| 07/23/2021 | Buy Now | 267.67% | Morgan Stanley | Michael Cyprys | — | Maintains | Overweight | Get Alert |
| 07/22/2021 | Buy Now | 231.24% | Deutsche Bank | Brian Bedell | — | Maintains | Buy | Get Alert |
| 07/22/2021 | Buy Now | 219.64% | Citigroup | Ben Herbert | — | Maintains | Neutral | Get Alert |
| 07/16/2021 | Buy Now | 244.48% | Morgan Stanley | Michael Cyprys | — | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Nasdaq (NDAQ) stock?
The latest price target for Nasdaq (NASDAQ:NDAQ) was reported by Argus Research on May 14, 2024. The analyst firm set a price target for $66.00 expecting NDAQ to rise to within 12 months (a possible 9.31% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Nasdaq (NDAQ)?
The latest analyst rating for Nasdaq (NASDAQ:NDAQ) was provided by Argus Research, and Nasdaq maintained their buy rating.
When was the last upgrade for Nasdaq (NDAQ)?
The last upgrade for Nasdaq Inc happened on April 9, 2024 when Morgan Stanley raised their price target to $80. Morgan Stanley previously had an equal-weight for Nasdaq Inc.
When was the last downgrade for Nasdaq (NDAQ)?
The last downgrade for Nasdaq Inc happened on May 8, 2024 when Rosenblatt changed their price target from $76 to $64 for Nasdaq Inc.
When is the next analyst rating going to be posted or updated for Nasdaq (NDAQ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nasdaq, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nasdaq was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.
Is the Analyst Rating Nasdaq (NDAQ) correct?
While ratings are subjective and will change, the latest Nasdaq (NDAQ) rating was a maintained with a price target of $64.00 to $66.00. The current price Nasdaq (NDAQ) is trading at is $60.38, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.